Andre B.
- Country
- Germany
- Department
- Klinik fur Pneumologie und Beatmungsmedizin
Research Overview
Data & Insights
Has run more than one trial at 1 of 101 partner sites.
Specializations
Lung Cancer Research
This investigator specializes in the treatment of advanced lung malignancies, with particular emphasis on small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC).
- Small Cell Lung Cancer Treatment Strategies
- NSCLC with EGFR Mutations
- Advanced Treatment Sequencing
Their research encompasses targeted therapeutic approaches for patients with relapsed disease conditions.
Molecular Oncology
The investigator focuses on precision medicine approaches in lung cancer, particularly involving EGFR mutation analysis and targeted therapies in non-squamous NSCLC.
- EGFR-TKI Treatment Protocols
- T790M Mutation Assessment
- Molecular Response Monitoring
Their work involves evaluation of sequential therapy approaches in molecularly defined patient populations.
Treatment Innovation
The investigator studies novel therapeutic agents and combinations for lung cancer treatment, including targeted molecular therapies and conventional chemotherapy approaches.
- Novel Agent Development
- Combination Therapy Strategies
- Treatment Resistance Management
Their research includes comparative assessments of different therapeutic sequences and combinations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.